ICON, which builds homes using 3D printing, has closed on $56 million in Series C funding co-led by Norwest Venture Partners ...

Lake Street analyst Thomas Flaten maintained a Buy rating on Evaxion Biotech (EVAX – Research Report) today and set a price target of $6.00.

The Janus Henderson Global Sustainable Equity Fund returned -5.88% for Q4 2024. Click here to read the full commentary.

Morgan Stanley analyst Michael Ulz maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...

Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...

The Janus Henderson Global Sustainable Equity Managed Account Portfolio returned -5.71% (gross) for Q4 2024. Click here to ...

ICON Plc 's stock (NASDAQ:ICLR) has reached a 52-week low, dipping to $183.31, as the company navigates through a turbulent market environment. With a market capitalization of $15.19 billion and a P/E ...

Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies. You can obtain detailed information about the use of cookies ...

NEW YORK (AP) — Tory Burch not only put her own twist on American sportswear in her new fall/winter collection at New York Fashion Week — she made it “twist-ed,” with exaggerated shapes and details, a ...

Spire Wealth Management boosted its position in shares of Avery Dennison Co. (NYSE:AVY – Free Report) by 76.0% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 301 shares ...

With over 150 curated sessions led by 300 industry experts, VIV Asia 2025 provides an unparalleled platform for knowledge-building and networking.

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.